AAAAAA
Results: 1-25/49
Authors:
ELISEN MGLM
BOUMA BN
CHURCH FC
MEIJERS JCM
Citation: Mglm. Elisen et al., INHIBITION OF SERINE PROTEASES BY REACTIVE-SITE MUTANTS OF PROTEIN-C INHIBITOR (PLASMINOGEN-ACTIVATOR INHIBITOR-3), FIBRINOLYSIS & PROTEOLYSIS, 12(5), 1998, pp. 283-291
Authors:
BAUMAN SJ
CHURCH FC
Citation: Sj. Bauman et Fc. Church, ENHANCED ANTITHROMBOTIC PROPERTIES OF HEPARIN-COFACTOR-II THROUGH SITE-DIRECTED MUTAGENESIS, The FASEB journal, 12(5), 1998, pp. 5528-5528
Authors:
MYLES T
CHURCH FC
WHINNA HC
MONARD D
STONE SR
Citation: T. Myles et al., ROLE OF THROMBIN ANION-BINDING EXOSITE-I IN THE FORMATION OF THROMBIN-SERPIN COMPLEXES, The Journal of biological chemistry, 273(47), 1998, pp. 31203-31208
Authors:
NEESE LL
WOLFE CA
CHURCH FC
Citation: Ll. Neese et al., CONTRIBUTION OF BASIC RESIDUES OF THE D-HELICE AND H-HELICE IN HEPARIN-BINDING TO PROTEIN-C INHIBITOR, Archives of biochemistry and biophysics (Print), 355(1), 1998, pp. 101-108
Authors:
MELAMED NG
GOETTGE KL
CHURCH FC
Citation: Ng. Melamed et al., HEPARIN-BINDING SITE IN AN ENGINEERED BETA-1 DOMAIN OF STAPHYLOCOCCALIGG-BINDING PROTEIN-G, The FASEB journal, 11(9), 1997, pp. 1743-1743
Authors:
WAGNER WD
SHIRK RA
CHURCH FC
Citation: Wd. Wagner et al., BIGLYCAN, IS INCREASED IN THE HUMAN ATHEROSCLEROTIC PLAQUE, AND IS DEFECTIVE IN REGULATION OF THROMBIN VIA HEPARIN-COFACTOR-II ACTIVATION, The FASEB journal, 11(3), 1997, pp. 1837-1837
Authors:
NEESE LL
WOLFE CA
CHURCH FC
Citation: Ll. Neese et al., PROBING THE HEPARIN-BINDING SITE OF PROTEIN-C INHIBITOR BY SITE-DIRECTED MUTAGENESIS, Thrombosis and haemostasis, 1997, pp. 1420-1420
Authors:
COOPER ST
REZAIE AR
ESMON CT
CHURCH FC
Citation: St. Cooper et al., ROLE OF ANION-BINDING EXOSITE-2 OF THROMBIN DURING GLYCOSAMINOGLYCAN-CATALYZED INHIBITION OF PROTEIN-C INHIBITOR AND HEPARIN-COFACTOR-II, Thrombosis and haemostasis, 1997, pp. 1422-1422
Authors:
WU HF
CHURCH FC
Citation: Hf. Wu et Fc. Church, MODIFICATION OF THROMBOMODULIN COFACTOR ACTIVITY BY LACTOFERRIN N-TERMINALPEPTIDES, Thrombosis and haemostasis, 1997, pp. 2246-2246
Authors:
JACKSON TP
COOPER ST
CHURCH FC
Citation: Tp. Jackson et al., ASSESSMENT OF THE INTERACTION BETWEEN UROKINASE AND REACTIVE-SITE MUTANTS OF PROTEIN-C INHIBITOR, Journal of protein chemistry, 16(8), 1997, pp. 819-828
Authors:
CIACCIA AV
MONROE DM
CHURCH FC
Citation: Av. Ciaccia et al., ARGININE-200 OF HEPARIN-COFACTOR-II PROMOTES INTRAMOLECULAR INTERACTIONS OF THE ACIDIC DOMAIN - IMPLICATION FOR THROMBIN INHIBITION, The Journal of biological chemistry, 272(22), 1997, pp. 14074-14079
Authors:
CIACCIA AV
WILLEMZE AJ
CHURCH FC
Citation: Av. Ciaccia et al., HEPARIN PROMOTES PROTEOLYTIC INACTIVATION BY THROMBIN OF A REACTIVE-SITE MUTANT (L444R) OF RECOMBINANT HEPARIN-COFACTOR-II, The Journal of biological chemistry, 272(2), 1997, pp. 888-893
Authors:
MYLES T
CHURCH FC
WHINNA HC
MONARD D
STONE SR
Citation: T. Myles et al., ROLE OF THROMBIN UNION-BINDING EXOSITE-I DURING FORMATION OF THROMBIN-SERPIN COMPLEXES, Blood, 90(10), 1997, pp. 118-118
Authors:
NEESE LL
GERLITZ B
COOPER ST
GRINNELL BW
CHURCH FC
Citation: Ll. Neese et al., IDENTIFICATION OF A HEPARIN-BINDING SITE IN ACTIVATED PROTEIN-C (LYS-37-39) AND ITS DETRIMENTAL INTERMOLECULAR INTERACTION WITH ARG-278 OF PROTEIN-C INHIBITOR, Blood, 90(10), 1997, pp. 642-642
Authors:
SHIRK RA
CHURCH FC
WAGNER WD
Citation: Ra. Shirk et al., ARTERIAL SMOOTH-MUSCLE CELL HEPARAN-SULFATE PROTEOGLYCANS ACCELERATE THROMBIN INHIBITION BY HEPARIN-COFACTOR-II, Arteriosclerosis, thrombosis, and vascular biology, 16(9), 1996, pp. 1138-1146
Authors:
COOPER ST
NEESE LL
DICUCCIO MN
LILES DK
HOFFMAN M
CHURCH FC
Citation: St. Cooper et al., VASCULAR LOCALIZATION OF THE HEPARIN-BINDING SERPINS ANTITHROMBIN, HEPARIN-COFACTOR-II, AND PROTEIN-C INHIBITOR, Clinical and applied thrombosis/hemostasis, 2(3), 1996, pp. 185-191
Authors:
WU HF
CHURCH FC
Citation: Hf. Wu et Fc. Church, THROMBOMODULIN COFACTOR ACTIVITY IS ENHANCED BY LACTOFERRIN N-TERMINAL PEPTIDES, The FASEB journal, 10(6), 1996, pp. 1380-1380
INTERACTION OF THROMBIN-60-INSERTION LOOP MUTANTS WITH ANTITHROMBIN, HEPARIN-COFACTOR-II AND HIRUDIN
Authors:
BAUMAN SJ
REZAIE AR
ESMON CT
CHURCH FC
Citation: Sj. Bauman et al., INTERACTION OF THROMBIN-60-INSERTION LOOP MUTANTS WITH ANTITHROMBIN, HEPARIN-COFACTOR-II AND HIRUDIN, The FASEB journal, 10(6), 1996, pp. 2348-2348
Authors:
HOFFMAN M
LOH KLM
LONGCHAMPS JM
CHURCH FC
Citation: M. Hoffman et al., HEPARIN-COFACTOR-II (HCII) IS ASSOCIATED WITH MACROPHAGES IN HEALING SKIN - A POTENTIAL ROLE FOR HCII IN CONTROLLING EXTRAVASCULAR THROMBINACTIVITY, Journal of leukocyte biology, 1996, pp. 57-57
Authors:
ELISEN MGLM
MASELAND MHH
CHURCH FC
BOUMA BN
MEIJERS JCM
Citation: Mglm. Elisen et al., ROLE OF THE A(-BINDING TO PROTEIN-C INHIBITOR() HELIX IN HEPARIN), Thrombosis and haemostasis, 75(5), 1996, pp. 760-766
Authors:
KOUNNAS MZ
CHURCH FC
ARGRAVES WS
STRICKLAND DK
Citation: Mz. Kounnas et al., CELLULAR INTERNALIZATION AND DEGRADATION OF ANTITHROMBIN III-THROMBIN, HEPARIN-COFACTOR II-THROMBIN, AND ALPHA(1)-ANTITRYPSIN-TRYPSIN COMPLEXES IS MEDIATED BY THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN, The Journal of biological chemistry, 271(11), 1996, pp. 6523-6529
Authors:
SHIRK RA
CHURCH FC
WAGNER WD
Citation: Ra. Shirk et al., ARTERIAL SMOOTH-MUSCLE CELL HEPARAN-SULFATE PROTEOGLYCANS ACCELERATE THROMBIN INHIBITION BY HEPARIN-COFACTOR-II, Molecular biology of the cell, 6, 1995, pp. 947-947
Authors:
CIACCIA AV
CUNNINGHAM EL
CHURCH FC
Citation: Av. Ciaccia et al., CHARACTERIZATION OF RECOMBINANT HEPARIN-COFACTOR-II EXPRESSED IN INSECT CELLS, Protein expression and purification, 6(6), 1995, pp. 806-812
Authors:
SLATE CA
WENINGER SC
CHURCH FC
ERICKSON BW
Citation: Ca. Slate et al., ENGINEERING OF 5 88-RESIDUE RECEPTOR-ADHESIVE MODULAR PROTEINS CONTAINING A PARALLEL ALPHA-HELICAL COILED-COIL AND 2 RGD LIGAND SITES, International journal of peptide & protein research, 45(3), 1995, pp. 290-298
Authors:
MELTON LG
CHURCH FC
ERICKSON BW
Citation: Lg. Melton et al., DESIGNED POLYANIONIC COILED-COIL PROTEINS - ACCELERATION OF HEPARIN-COFACTOR-II INHIBITION OF THROMBIN, International journal of peptide & protein research, 45(1), 1995, pp. 44-52